Davis Jefferson E 4
4 · Acer Therapeutics Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Davis Jefferson E
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-14+30,000→ 30,000 totalExercise: $1.67Exp: 2033-03-14→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option, which is made as part of the issuer's 2023 annual compensation cycle, vests and becomes exercisable over four years as follows: 25% of the shares vest on March 14, 2024, and the remaining 75% of the shares vest quarterly over the remaining three years.